Background and Purpose: An association between atrial septal aneurysm and embolic events has been suggested. Atrial septal aneurysm has been shown to be associated with patent foramen ovale and, in some reports, with mitral valve prolapse. These two latter cardiac disorders have been identified as potential risk factors for ischemic stroke. The aim of this prospective study was to assess the role of atrial septal aneurysm as an independent risk factor for stroke, especially for cryptogenic stroke.
trial septal aneurysm is a bulging of the atrial septum through the fossa ovalis into the right or the left atrium or both.1 First reported by Lang and Posselt2 in 1934, atrial septal aneurysm has been found in 1% of consecutive autopsies.' With the advent of two-dimensional echocardiography, atrial septal aneurysm has been reported more frequently in recent years,3-5 and an association of this cardiac abnormality with embolic events has been suggested.5-10 By use of transesophageal echocardiography, which is the method of choice for its detection," atrial septal aneu-rysm has been detected in 0.2% to 4% of unselected patients undergoing echocardiography and in 4% to 15% of patients with stroke.9 1'-1 A frequent association of atrial septal aneurysm with patent foramen ovale has been reported,1'5,8 9 and some have suggested an association with mitral valve prolapse4'15; the two latter cardiac disorders16'7 have previously been identified as potential risk factors for ischemic stroke.
The aims of this study were (1) to determine the prevalence of atrial septal aneurysm, patent foramen ovale, and mitral valve prolapse in young patients with stroke and in a control population by use of transesophageal and transthoracic echocardiography with a contrast study and (2) to assess the role of atrial septal aneurysm as an independent risk factor for stroke, especially for cryptogenic stroke.
Subjects and Methods Stroke Patients
Between October 1989 and December 1992, 100 consecutive patients were prospectively enrolled in this study. Inclusion criteria were (1) age between 15 and 55 years; (2) recent (<3 months) and completed (neurological deficit lasting >24 hours) ischemic stroke; and (3) patient's consent to undergo detailed etiological investigations (see below). One hundred thirty-five stroke patients <55 years old were screened to obtain the 100 patients who were included in the study. The 35 patients who did not enter the study were excluded because either they refused to undergo transesophageal echocardiography or angiography (in case of no obvious cause of stroke) or the cardiological investigations could not be performed according to our study protocol (echocardiography performed in another laboratory before the patient was referred to our neurological institutions or by a cardiologist not involved in the study). The patients were recruited in three neurological centers and investigated according to a standardized protocol including computed tomography and/or magnetic resonance imaging of the brain; cerebral angiography (except for patients with an obvious extra-arterial cause of stroke); electrocardiography; transthoracic and transesophageal echocardiography with a contrast study (see below); and laboratory studies (complete blood cell count; erythrocyte sedimentation rate; protein electrophoresis; antinuclear antibodies; glucose, serum cholesterol, and triglyceride levels; and prothrombin and activated partial thromboplastin times). Cerebral angiography was performed in 96 patients, in 65 (68%) within 2 weeks after stroke onset. Cerebral angiography was not performed in four patients with an obvious cause for their stroke. These four patients had normal ultrasonographic examination of cervical arteries and transcranial Doppler. In addition to the standard investigations, extensive platelet, coagulation, and fibrinolysis studies were performed in 80 patients. Antiphospholipid antibodies were assessed in 80 patients. A 24-hour electrocardiographic Holter recording was performed in 72 patients to detect possible arrhythmias. The following conditions were considered risk factors (and not causes) for stroke: hypertension (blood pressure >160/90 mm Hg at least twice before the stroke), diabetes mellitus (known fasting blood glucose concentration >5.6 mmol/L before the stroke), hypercholesterolemia (treated hypercholesterolemia before the stroke or cholesterol concentration >6.5 mmol/L the day after admission), current cigarette smoking, and current oral contraceptive use.
After completion of the etiological workup, stroke patients were classified into two groups according to the presence or absence of a probable or definite cause for stroke, which was defined as any disease that has been clearly linked to the occurrence of stroke: arteriopathies such as dissections,18 atherosclerosis with stenosis >50% of the corresponding vessel, or angiitis; major cardiac sources of embolism19 such as mitral stenosis, atrial fibrillation, acute myocardial infarction, infective endocarditis, intracardiac thrombus, or atrial myxoma; and coagulopathies and systemic disorders such as thrombocythemia, disseminated intravascular coagulation, or lupus erythematosus. Lacunar stroke due to small artery disease was diagnosed when a hypertensive patient had one of the four main lacunar syndromes and a small, deep infarct on computed tomography or magnetic resonance imaging. The diagnosis of migrainous infarction rested on the criteria of the International Headache Society.20 Patients who had no definite cause for stroke were diagnosed as having cryptogenic infarcts. This classification was performed independently by two neurologists who were blinded to the results of echocardiography in regard to the presence of an atrial septal aneurysm, a patent foramen ovale, or a mitral valve prolapse (but not in regard to other potential cardiac sources of embolism). The presence of risk factors for stroke was not taken into account for classifying the patients into the two groups. Sudden, nonprogressive onset of stroke, early loss of consciousness, hemorrhagic or cortico-subcortical territorial infarcts, and arterial occlusion on early angiography were considered to support the diagnosis of cerebral embolism.
A probable or definr-ite cause of stroke was found in 36 patients ( Table 1 ). The remaining 64 patients were diagnosed as having cryptogenic strokes. Except for the presence of stroke risk factors (Table 2) , the diagnostic evaluation of these patients was entirely negative or revealed abnormalities whose link to stroke could not be clearly established. Two patients had atherosclerotic nonstenotic plaques (<30% reduction in diameter) in tP<.001, patients with cryptogenic stroke vs control subjects. tP<.005, stroke patients vs control subjects. §P<.0001, patients with cryptogenic stroke vs control subjects. the appropriate vessel. Three patients had tortuous, elongated carotid or vertebral arteries. One patient had a history of drug addiction (marijuana), but no clear temporal relation between drug intake and stroke could be elicited. Low titers of antiphospholipid antibodies were present in 5 of the 54 patients of this group in whom the test was performed. Eleven patients had a prior history of migraine according to the criteria of the International Headache Society,20 but none of them fulfilled the criteria for migrainous infarction.
Control Group
This group comprised 50 consecutive patients prospectively selected from the patients referred to the echocardiography laboratories during the same recruitment period. The patients were selected as control subjects when they fulfilled the following criteria: (1) age between 15 and 55 years; (2) no past history of stroke or cardiac disorder; and (3) one of the following indications for transesophageal echocardiography: ruling out infective endocarditis in a patient with an unexplained fever (n= 31); evaluation before posterior fossa surgery in a seated position (n= 16); or suspected aortic dissection (n=3). Because of the risk of air embolism during posterior fossa surgery, contrast echocardiography was used systematically before surgery to investigate the possibility of a patent foramen ovale. If patent foramen ovale was proved to be present, the patient was operated on in a supine position. In the 50 patients, the echocardiographic evaluation was within normal limits except for the presence in some patients of the cardiac abnormalities under study.
Echocardiographic Studies
The same protocol was used for the patients with stroke and the control subjects. The echocardiographic studies were performed in two different laboratories by two experienced echocardiographers (L.C., A.C.) with either a Hewlett Packard 77020 or an Advanced Technology Laboratory Ultramark 9. The transesophageal echocardiography was performed after administration of pharyngeal anesthesia with a 10% lidocaine spray; a 5-MHz monoplane transesophageal echocardiographic probe was passed to 25 to 35 cm from the incisors and then manipulated to provide adequate views of both atria, appendage, atrial septum, mitral valve apparatus, and thoracic aorta. All examinations were recorded on videotape for subsequent playback and analysis. Echocardiography was performed within 2 weeks after stroke onset in 38% of patients. At the end of the study, videotape recordings from one laboratory were interpreted by the echocardiographer of the other laboratory. The two echocardiographers were blinded to the other's reading and the group the patient belonged to (control group, stroke of determined cause, or cryptogenic stroke). The diagnosis of atrial septal aneurysm and patent foramen ovale relied on transesophageal echocardiography with a contrast study and that of mitral valve prolapse, on two-dimensional transthoracic echocardiography. The echocardiographers disagreed on the presence or absence of an atrial septal aneurysm in one patient, on the size of the aneurysm in five patients, and on the presence or absence of a patent foramen ovale in five patients. They agreed on the presence or absence of a mitral valve prolapse in all patients. Disagreements between the blinded observers were resolved by unblinded consensus review.
Atrial septal aneurysm was diagnosed when the atrial septum appeared abnormally redundant and mobile and exhibited an excursion into the left or the right atrium or both of at least 6 mm. The distance between the plane of the atrial septum and the point of maximal aneurysmal bulging was measured from the stoppedframe image. In case of phasic excursion, we considered the sum of the outpouching in both atria. Atrial septal aneurysms were subdivided according to their maximal excursion: 6 to 10 mm, 11 to 15 mm, or >15 mm of excursion (Figs 1 and 2) . The cut-off point of 6 mm7 was selected because it was the smallest excursion for which both echocardiographers agreed consistently about the presence of an abnormally redundant atrial septum. Although the thickening of the aneurysmal membrane is difficult to measure precisely,9 we considered as abnormal a thickening of the membrane of >3.5 mm.
For patent foramen ovale, the echocardiographic detection of interatrial right-to-left shunting (presumed to be due to a patent foramen ovale in most cases) requires intravenous administration of an echocardiogram-detectable contrast material. The contrast material was prepared by use of two syringes mounted on a three-way stopcock to mix saline or gelatin with air, and 10 mL of this mixture was injected in bolus into an antecubital vein. Three to six contrast injections were systematically performed in each patient, in the resting state and during provocative maneuvers (Valsalva maneuver and cough test), to transiently reverse the interatrial pressure gradient. Although most patients received slight sedation with oral midazolam (5 mg), all (patients as well as control subjects) were able, when ordered, to cough vigorously and to perform a Valsalva maneuver. The echocardiographic diagnosis of patent foramen ovale was based on the appearance of more than five microcavitations, either spontaneously or after provocative maneuvers, into the left atrium within three cardiac cycles of the total opacification of the right atrium (Fig 3) .
Mitral valve prolapse was defined on transthoracie echocardiography as mitral leaflet displacement beyond the plane of the mitral annulus and into the left atrium in the parasternal long-axis view.2' The leaflets were measured in the parasternal long-axis view during diastole.
Statistical Analysis
Percentages were compared by X2 tests and, for small numbers, by Fisher's exact test. Differences in age between stroke patients and control subjects were assessed by the t test for unpaired data. All comparisons were two-tailed. Three types of stepwise logistic regression analyses were performed. In the first analysis (model A), we used a model with atrial septal aneurysm, patent foramen ovale, and mitral valve prolapse as independent variables and stroke as a dependent variable to evaluate the statistical association of these cardiac abnormalities with stroke. The significance levels for variables to enter and remain in the model were set at a-0.1. Variables entered the model if P<.1 by score test and remained in the model if P<.1 by the likelihood ratio test. Odds ratios with 95% confidence intervals were calculated from the fl-coefficients and the standard errors. To assess the role of atrial septal aneurysm and patent foramen ovale in isolation from or in association with each other, we used a model with an independent variable divided into four categories (no patent foramen ovale or atrial septal aneurysm, isolated patent foramen ovale, isolated atrial septal aneurysm, presence of both cardiac abnormalities) and stroke as a dependent variable (model B). Finally, we assessed the role of the aneurysm size by use of a model with atrial septal aneurysm divided into three categories (no atrial septal aneurysm, 6 to 10 mm of excursion, > 10 mm of excursion) and patent foramen ovale as independent variables and stroke as dependent variable (model C). These three types of analyses (models A, B, and C) were also performed after the 36 patients with a definite or probable cause for their stroke were excluded.
Results
The demographic characteristics of stroke and control patients are shown in Table 2 . Mean age, sex ratio, and frequency of stroke risk factors did not differ significantly between control subjects and stroke patients or between control subjects and patients with cryptogenic strokes.
Atrial Septal Aneurysm
The prevalence of atrial septal aneurysm was 8% (95% con-fidence interval, 2% to 19%) in the control population and 28% (95% confidence interval, 19% to 37%) in the 100 patients with stroke (x-=8.0, df=1, P<.005) ( Table 2 ). An atrial septal aneurysm was also detected in a higher proportion of patients with cryptogenic stroke (39.1%; 95% confidence interval, 27% to 51%) compared with the control population (X2= 14.3, df= 1, P<.001).
The characteristics of patients with and without atrial septal aneurysm are shown in Table 3 . No significant association was detected with age, sex, or stroke risk factors. A strong association was found between atrial septal aneurysm and patent foramen ovale. Of the 150 patients in the entire study, 23 of 32 (71.9%) with atrial septal aneurysm also had a patent foramen ovale, compared with 29 of 118 (24.6%) without atrial septal Among the 25 patients with cryptogenic stroke and atrial septal aneurysm, 19 had stroke of sudden, nonprogressive onset, 16 had cortico-subcortical territorial infarct, and 14 had angiography within 2 weeks of stroke onset showing embolic occlusion in 3. Twenty-fourhour Holter monitoring did not reveal emboligenic arrhythmias in the 23 of 25 patients in whom it was performed. None of the patients with atrial septal aneurysm had intracardiac thrombus. The membrane of the aneurysm was considered thickened in 10 of 25 patients with cryptogenic stroke and in 1 of 4 control subjects.
Patent Foramen Ovale
The prevalence of patent foramen ovale was 18% (95% confidence interval, 8% to 32%) in the control population and 43% (95% confidence interval, 33% to 53%) in the 100 patients with stroke (X2=9.2, df=l, P<.005). Patients with cryptogenic stroke had a significantly higher prevalence of patent foramen ovale (56.3%; 95% confidence interval, 44% to 68%) than did control subjects (x2= 17.2, df= 1, P<.0001).
The patients with a patent foramen ovale were 38.6+9.4 years of age, which was not significantly different from the patients without patent foramen ovale, who were 40.7±9.4 years of age (t=1.3, P=.2). Thirtyone of the 52 patients with a patent foramen ovale were men, compared with 62 men among the 98 patients without patent foramen ovale (X 2=0.2, df-1, not significant). No significant association was detected between patent foramen ovale and stroke risk factors. Of 52 patients with a patent foramen ovale, 7 (13.5%) also had mitral valve prolapse, compared with 4 (4.1%) of 98 patients without patent foramen ovale (Fisher's exact test, 0.049).
Mitral Valve Prolapse
The prevalence of mitral valve prolapse did not differ significantly between the control subjects (6%) and the patients with stroke (8%) or the patients with cryptogenic stroke (7.8%). In two control subjects and four patients with stroke, at least one of the mitral valve leaflets was thicker than 2.5 mm. None had leaflets >5 mm thick.
Stepwise Logistic Regression Analyses
Stroke patients (n=100) compared with control subjects. Stepwise logistic regression analysis with atrial septal aneurysm, patent foramen ovale, and mitral valve prolapse as independent variables and stroke as dependent variable (model A) showed that patent foramen ovale and atrial septal aneurysm but not mitral valve prolapse were significantly associated with stroke. The odds ratios were 2.5 (95% confidence interval, 1.1 to 6.1; P=.03) for patent foramen ovale and 3.0 (95% confidence interval, 1.0 to 9.8; P=.05) for atrial septal aneurysm ( Table 4 ). The results were similar after controlling for age, sex, and stroke risk factors.
The stepwise logistic regression analysis with atrial septal aneurysm and patent foramen ovale in isolation from or in association with each other as independent variables and stroke as dependent variable (model B) selected atrial septal aneurysm in association with patent foramen ovale as the best predictor of stroke ( Table 4 ). The stroke odds of a patient with both cardiac abnormalities were 16.4 times (95% confidence interval, 2.1 to 129) the stroke odds of a patient with none of these cardiac disorders. Isolated patent foramen ovale and isolated atrial septal aneurysm were not selected as statistically significant predictors of stroke. However, the number of patients in the respective groups with isolated atrial septal aneurysm or isolated patent foramen ovale was small. Table 4 also shows the odds ratios associated with small (6 to 10 mm of excursion) and larger (>10 mm of excursion) atrial septal aneurysms (model C). For a patient with an atrial septal aneurysm of >10 mm of excursion, the stroke odds were approximately seven times the stroke odds of a patient with atrial septal aneurysm of < 10 mm.
Patients with cryptogenic stroke compared with control subjects. Results were similar when the analyses were restricted to the patients with cryptogenic stroke. The only difference concerned the analysis of the specific role of atrial septal aneurysm and patent foramen ovale and their association (model B). In this analysis, not only the association of both cardiac disorders but also the presence of an isolated patent foramen ovale were selected as factors significantly associated with cryptogenic stroke (Table 4 ).
Discussion
The aim of this study was to assess the possible role of atrial septal aneurysm, patent foramen ovale, and mitral valve prolapse as independent risk factors for stroke, especially for cryptogenic stroke. We selected patients <55 years of age because, in the elderly, the higher prevalence of large-vessel atherosclerosis or small-artery disease makes the diagnosis of cryptogenic stroke less frequent than in the young. The strict criteria adopted for defining infarcts of determined cause and the nature of the neurology departments involved in this study (tertiary referral centers) could explain our high proportion of cryptogenic strokes. The control group was prospectively selected among patients in whom the indication of transesophageal echocardiography was unlikely to be related to the presence or absence of the cardiac disorders under study. The echocardiographic studies were performed and interpreted in the same fashion for the stroke patients and the control subjects.
At the beginning of this study, only monoplane transesophageal echocardiography was available in our institutions. The use of biplane equipment in future studies will allow a more detailed examination of the atrial septum and enhance the sensitivity for the detection of other potential cardiac sources of embolism. To minimize the information bias, the diagnosis of cryptogenic stroke was determined by two neurologists blinded to the results of echocardiography (in regard to the presence of the cardiac abnormalities under study). Similarly, the echocardiographers were blinded to the group the patient belonged to and the results of the patient's neurological workup. Nevertheless, given the difficulties in proving causality between a potential cause of cerebral ischemia and the occurrence of stroke in a given patient, we performed the analyses with both the 100 patients with ischemic stroke and the patients considered to have cryptogenic stroke. The present study showed that patients with stroke had a significantly higher prevalence of atrial septal aneurysm (28%) than did the control subjects (8%). The difference was even more pronounced (39.1% versus 8%) when only patients with cryptogenic stroke were taken into account. In the largest study using transesophageal echocardiography, Pearson et a19 found atrial septal aneurysm (defined as a total excursion of the atrial septum of at least 11 mm) in 15% of 132 stroke patients with unexplained ischemic stroke and 4% of 277 patients referred for evaluation of various cardiac disorders. These percentages are close to ours if we consider only patients with atrial septal aneurysm of > 10 mm excursion ( Table 2 ). In fact, there is no broadly accepted cutoff point between a slightly mobile ("floppy") and an aneurysmal atrial septum. 4, 7 In the present controlled study, we adopted a nonrestrictive definition of atrial septal aneurysm (>6 mm) to analyze the potential value of the aneurysm size in the risk of stroke. The stroke odds were 1.2 for atrial septal aneurysm with 6 to 10 mm excursion and 8.5 for atrial septal aneurysm with > 10 mm excursion, which strongly suggests a size effect of atrial septal aneurysm in the risk of stroke.
The patients with stroke also had a significantly higher prevalence of patent foramen ovale (43% in the 100 patients with stroke; 56.3% in those with cryptogenic stroke) than did the control subjects (18%). This confirms the results obtained by one of us16 in a previous case-control study in which the diagnosis of patent foramen ovale relied on transthoracic contrast echocardiography. In this study, the prevalence of patent foramen ovale was 40% in 60 stroke patients <55 years old, 54% in those with cryptogenic stroke, and 10% in 100 control subjects. Similar results were obtained by Webster et a122 in 40 stroke patients and 40 matched control subjects <40 years of age and by Di Tullio et a123 in a group of 146 patients with stroke unselected for age.
The exact role of mitral valve prolapse in cerebral ischemia is still debated. Its prevalence varies from 2% to >30% in young adults with stroke.24 These widely differing prevalences may be explained by a bias in echocardiographic interpretation. In the present study, the diagnosis relied on the parasternal long-axis view because of the nonspecificity of apical imaging alone.21 By this definition, we did not find any significant difference between the patients with stroke and the control subjects in regard to the prevalence of mitral valve prolapse. The exclusion of patients with transient ischemic attacks from this study may also partly explain our low prevalence of mitral valve prolapse in patients with strokes, since this cardiac abnormality seems to be more prone to induce transient ischemic attacks than disabling strokes. 24 Our study confirms the strong association between atrial septal aneurysm and patent foramen ovale. Of 32 patients with atrial septal aneurysm, 72% had associated patent foramen ovale compared with 71% to 83% in previous studies using transesophageal echocardiography. 8, 9 In the present study, stepwise logistic regression analysis (model A) showed that both atrial septal aneurysm and patent foramen ovale were significantly associated with stroke (after the presence of the other was controlled for). In the analysis assessing the role of each cardiac disorder in isolation from or association with each other, the simultaneous presence of both cardiac disorders was the strongest predictor of stroke. This suggests that each of the two cardiac disorders contributes significantly to the risk of stroke and that their association has a marked synergistic effect.
The exact mechanism of stroke in patients with atrial septal aneurysm is unsettled. On the basis of the frequent association of atrial septal aneurysm with a patent foramen ovale, paradoxical embolism has been suggested as the cause of embolic events. However, the precise mechanism of patent foramen ovale-associated stroke itself remains controversial.2526 A previous study from our group27 suggested that paradoxical embolism might not be the prevalent mechanism of stroke in patients with patent foramen ovale. Another potential mechanism for the association between atrial septal aneurysm and stroke is direct embolization from thrombi formed within the aneurysm. Silver and Dorsey' described the pathological findings in sixteen patients with fossa ovalis aneurysm among 1578 consecutive autopsies of adults aged 73 to 81 years. All were clinically asymptomatic. The aneurysms projected 1.1 to 2.4 cm beyond the plane of the atrial septum, and all but two projected into the right atrium. They documented the presence of a thrombus at the base of an aneurysm in one case and noted occasional fibrinthrombus tags on the convex surface of the aneurysm. In single cases, a thrombus within an aneurysm has been observed at surgical resection28 or transesophageal echocardiography.8 Thus, cerebral embolism might result from migration of a thrombus formed on the left atrial side of the aneurysm or from embolization of thrombi formed on the right atrial side of the aneurysm through an interatrial communication. The latter mechanism is consistent with our finding of a strong synergistic effect between atrial septal aneurysm and patent foramen ovale. It must be stressed, however, that none of the atrial septal aneurysms we visualized contained defects that resembled thrombus. This may be a result of the time elapsed between the stroke and echocardiography or the small size of the thrombi, which made them undetectable by echocardiography. Whether the thickening of the aneurysmal membrane found in 10 of our patients with cryptogenic stroke represented a surface made rough by small fibrin-thrombus tags remains to be demonstrated. Another cause of systemic embolism might be paroxysmal supraventricular arrhythmias, which have been observed in patients with atrial septal aneurysms.4 Our data do not support this hypothesis, since none of our patients with atrial septal aneurysm and cryptogenic stroke were found to have emboligenic arrhythmias on early standard cardiac examination or delayed 24-hour electrocardiographic Holter monitoring.
In conclusion, this study shows that atrial septal aneurysm and patent foramen ovale, considered individually, are significantly associated with stroke (especially with cryptogenic stroke) in adults <55 years old. The simultaneous presence of both cardiac disorders appears to have a strong synergistic effect. Atrial septal aneurysms of >10 mm of excursion are associated with a higher risk of stroke. Longitudinal studies of patients with atrial septal aneurysm and/or patent foramen ovale are needed to assess the absolute risk of initial or recurrent stroke associated with these cardiac abnormalities.
